Preparation of a transdermal delivery system and effect of membrane type for scopolamine drug

Iranian Polymer Journal (English Edition)

Volumn 11, Issue 4, 2002, Pages 245-250

  Arabi, Hassan ^a   Hashemi, Seyed Ali ^a   Ajdari, Navid ^a  

^a IRAN POLYMER AND PETROCHEMICAL INSTITUTE   (Iran)

Author keywords

Delivery; Drug; Membrane; Scopolamine; Transdermal

Indexed keywords

DRUG THERAPY; POLYMERS; POROSITY; SKIN;

SCOPOLAMINE DRUGS;

MEMBRANES;

EID: 0036663538     PISSN: 10261265     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Guyot M. and Fawaz F., "Design and in vitro evaluation of adhesive matrix for transdermal delivery of propranolol", Int. J. Pharma., 204, 171-182 (2000).
2. Finnin B.C. and Morgan T.M., "Transdermal penetration enhancers: Application, limitation and potential", J. pharma. Sci., 88, 10 (1999).
3. Mantelle J.A., "Delivery vehicle", Medical Adhesives, www.adhesivesage.com, April (2000).
4. Buskirk G.A., "Scale up of adhesive transdermal drug delivery systems", Pharma. Res., 14, 7 (1997).
5. Manitz R., "Mathematical modeling of dermal and transdermal drug delivery", J. pharma. Sci., 87, 7 (1998).
6. Venkatraman S. and Gale R., "Skin adhesives and skin adhesion 1-Transdermal drug delivery systems", Biomaterials, 19, 1119-1136(1998).
7. Kurnik R.T. and Potts R.O., "Modling of diffusion and crystal dissolution in controlled release systems", J. Con. Rel., 45, 257-264 (1997).
8. D'Mello M., "Transdermal patch delivery", Scrip Reports, October (1995).
9. Houze D., "Acrylic pressure sensitive adhesive blends for transdermal drug delivery", Proceed. Int. Symp. Control. Rel. Bioact. Mater., 26 (1999).
10. Chein Y.W., "Transdermal systemic drug delivery recent development and future prospects", S.T.P Pharma. Sci., 1,1, 5-23 (1991).
11. Chen Y.W., Transdermal Controlled Systemic Medications, Chapter 1., Marcel and Dekker., New York (1987).
12. Mazzo D.J., Fong E.F., and Biffar S., "A comparison of test methods for determining in vitro drug release from transdermal delivery dosage forms", J. Pharma. & Biomed. Ana., 4, 5, 601-607 (1986).
13. Bronaugh R.L. and Stewart R.F., "Methods for in vitro percutaneous absorption studies (iv): The flow-through diffusion cell", J. Pharma. Sci., 74, 1, 64-67 (1985).
14. Morimoto Y., Seki T., Sugibayash K., Juni K., and Miyazaki S., "Basic studies on controlled transdermal delirevy of nicardipine hydrochloride using ethylene-vinyl acetate and ethylene-vinyl alcohol copolymer membranes", Chem. Pharm. Bult., 36, 7, 2633-2641 (1988).
15. Benowitz N.L., Chan K., Denaro C.P., and Jacob P., "Stable isotope method for studying transdermal drug absorption: The nicotine patch", Clinic. Pharma. & Thera., 50, 1, 286-293 (1991).
16. Good W.R., "Transderm-nitro: Controlled delivery of nitroglycerine via the transdermal route", Drug. Develop. Ind. Pharm., 9, 647-670 (1983).
17. Kanig J. and Goodman H., "Evaluative procedures for film-forming materials used in pharmaceutical application", Pharma. Acta., 60, 11 (1984).
18. Ratner B.D., Hoffman A.S., Schoen F.J., and Lemoms J.E., "Biomaterials science", in Introduction to Materials in Medicine, Rather B.D., Ed., AP, 348 (1996).